NewsSource: EClinCloud

Conference Invitation | Join EClinCloud at the Tongxieyi T20 Conference

1 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.

Article image

Click the image above to view the detailed conference agenda



From July 11 to 13, the Tongxieyi T20 Conference will be held at Kempinski Hotel Suzhou. Focusing on "The Future Path of Pharmaceutical Innovation in China," the conference features 30+ thematic forums and brings together more than 300 expert speakers from the radiopharmaceutical, antibody, clinical research, and peptide fields for forward-looking, authoritative, and prescient discussions.

As a technology company dedicated to clinical R&D, the EClinCloud team will host a networking area at Booth B26 during the conference and looks forward to discussing digital clinical trial solutions with clinical research professionals.


EClinCloud Booth Location:

Floor 1 (Booth B26)

We welcome all colleagues to visit and connect with us!

Article image


Participate in booth activities and follow us on-site to enter the lucky draw

Participate for a chance to win a prize!

Event gifts are limited and available on a first-come, first-served basis.
Article image

EClinCloud looks forward to seeing you there

……


 Conference Details
Conference Dates: July 11–13, 2024
Conference Venue: Kempinski Hotel Suzhou






About EClinCloud

EClinCloud is a technology company dedicated to clinical R&D. It provides an integrated, interoperable all-in-one clinical trial cloud platform (spanning technology products and offerings such as eCOA, CTMS, eTMF, EDC, RTSM, and RM, and including solutions such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) as well as clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system, ophthalmology, and others). Combining cutting-edge technology with life sciences data, EClinCloud builds a globally leading, patient-centric clinical evidence support SaaS cloud platform to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.







Article image

Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.